Product Information
TIROSINT 13 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.5000 per EA under NDC 71858000504. Its NADAC has been published 249 times since Feb 6, 2019.
The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
13 ug/1
Manufacturer
IBSA Pharma Inc.NDC
71858000504
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
7/1/2024
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021924On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for TIROSINT 13 MCG CAPSULE has been published 249 times since Feb 6, 2019, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5000 per EA |
|---|---|
| All-time high | $4.5000 (Oct 2, 2024) |
| All-time low | $4.1124 (Feb 6, 2019) |
| Median price | $4.2780 |
| Average price | $4.2934 |
| Largest weekly change | +4.0% (Dec 25, 2019) |
| Weeks tracked | 249 |
| Tracking since | Feb 6, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIROSINT 13 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 13 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.5000 per EA (NDC 71858000504), effective Oct 2, 2024.
How has the price of TIROSINT 13 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIROSINT 13 MCG CAPSULE has risen 9.4%. It has been tracked across 249 weekly CMS publications since Feb 6, 2019.
What are the highest and lowest recorded NADAC prices for TIROSINT 13 MCG CAPSULE?
Since Feb 6, 2019, the NADAC for TIROSINT 13 MCG CAPSULE has ranged from a low of $4.1124 (Feb 6, 2019) to a high of $4.5000 (Oct 2, 2024), with a median of $4.2780 per EA.
Are there cheaper alternatives to TIROSINT 13 MCG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LEVOTHYROXINE 13 MCG CAPSULE, is $2.6972 per EA — about 40% below TIROSINT 13 MCG CAPSULE.
Who manufactures TIROSINT 13 MCG CAPSULE?
TIROSINT 13 MCG CAPSULE (NDC 71858000504) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification